Bridgeway Capital Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.95M Buy
138,153
+39,060
+39% +$734K 0.05% 451
2026
Q1
$1.73M Buy
99,093
+5,856
+6% +$116K 0.03% 567
2025
Q4
$1.83M Buy
93,237
+5,782
+7% +$120K 0.04% 564
2025
Q3
$2.41M Buy
87,455
+34,588
+65% +$1.06M 0.05% 494
2025
Q2
$1.61M Buy
52,867
+2,384
+5% +$67.7K 0.04% 570
2025
Q1
$1.36M Buy
+50,483
New +$1.6M 0.03% 588
2015
Q4
Sell
-6,800
Closed -$456K 1500
2015
Q3
$456K Sell
6,800
-1,200
-15% -$84.9K 0.01% 1078
2015
Q2
$547K Sell
8,000
-1,800
-18% -$114K 0.01% 1037
2015
Q1
$544K Buy
9,800
+1,000
+11% +$51.3K 0.01% 1064
2014
Q4
$451K Sell
8,800
-4,200
-32% -$206K 0.01% 1111
2014
Q3
$479K Hold
13,000
0.01% 1092
2014
Q2
$508K Hold
13,000
0.01% 1085
2014
Q1
$490K Sell
13,000
-1,400
-10% -$48.9K 0.01% 1083
2013
Q4
$544K Buy
14,400
+1,600
+13% +$61.2K 0.02% 1008
2013
Q3
$555K Sell
12,800
-3,600
-22% -$144K 0.02% 980
2013
Q2
$594K Buy
+16,400
New +$498K 0.02% 873

Other funds holding USNA

Bridgeway Capital Management's USNA Position: Q2 2026 in Review

Bridgeway Capital Management increased its Usana Health Sciences (USNA) stake by 39% in Q2 2026, buying an estimated $734K and bringing the position to 138,153 shares worth $2.95M. The position accounts for 0.05% of the portfolio, ranked #451.

Bridgeway Capital Management first reported a position in USNA in Q2 2013 and has held it in 16 quarters since. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Bridgeway Capital Management held 138,153 shares of Usana Health Sciences worth $2.95M as of Q2 2026.
  • Bridgeway Capital Management bought 39,060 Usana Health Sciences shares in Q2 2026, an estimated $734K.
  • Usana Health Sciences made up 0.05% of Bridgeway Capital Management's portfolio in Q2 2026, its #451 holding.
  • Bridgeway Capital Management first reported a position in Usana Health Sciences in Q2 2013 and has held it in 16 quarters since.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.